Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Drug metabolism and liver disease: a drug-gene-environment interaction.

Zgheib NK, Branch RA.

Drug Metab Rev. 2017 Feb;49(1):35-55. doi: 10.1080/03602532.2016.1271807. Epub 2017 Jan 23. Review.

PMID:
27957864
2.

The relationship between pulmonary emphysema and kidney function in smokers.

Chandra D, Stamm JA, Palevsky PM, Leader JK, Fuhrman CR, Zhang Y, Bon J, Duncan SR, Branch RA, Weissfeld J, Gur D, Gladwin MT, Sciurba FC.

Chest. 2012 Sep;142(3):655-662. doi: 10.1378/chest.11-1456.

3.

A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.

Stewart NA, Buch SC, Conrads TP, Branch RA.

Analyst. 2011 Feb 7;136(3):605-12. doi: 10.1039/c0an00643b. Epub 2010 Nov 25.

4.

Significance of increased serum GGTP levels in HCC patients.

Carr BI, Pancoska P, Branch RA.

Hepatogastroenterology. 2010 Jul-Aug;57(101):869-74.

PMID:
21033244
5.

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.

Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, Zhang Y, Leader JK, Gur D, Greenspan SL, Sciurba FC.

Am J Respir Crit Care Med. 2011 Apr 1;183(7):885-90. doi: 10.1164/rccm.201004-0666OC. Epub 2010 Oct 8.

6.

Low alpha-fetoprotein hepatocellular carcinoma.

Carr BI, Pancoska P, Branch RA.

J Gastroenterol Hepatol. 2010 Sep;25(9):1543-9. doi: 10.1111/j.1440-1746.2010.06303.x.

PMID:
20796153
7.

HCC in young adults.

Carr BI, Pancoska P, Branch RA.

Hepatogastroenterology. 2010 May-Jun;57(99-100):436-40.

PMID:
20698204
8.

Network-based analysis of survival for unresectable hepatocellular carcinoma.

Pancoska P, Carr BI, Branch RA.

Semin Oncol. 2010 Apr;37(2):170-81. doi: 10.1053/j.seminoncol.2010.03.008.

PMID:
20494709
9.

Team building: electronic management-clinical translational research (eM-CTR) systems.

Cecchetti AA, Parmanto B, Vecchio ML, Ahmad S, Buch S, Zgheib NK, Groark SJ Jr, Vemuganti A, Romkes M, Sciurba F, Donahoe MP, Branch RA.

Clin Transl Sci. 2009 Dec;2(6):449-55. doi: 10.1111/j.1752-8062.2009.00157.x.

10.

Feasibility of adolescents to conduct community-based participatory research on obesity and diabetes in rural Appalachia.

Bardwell G, Morton C, Chester A, Pancoska P, Buch S, Cecchetti A, Vecchio M, Paulsen S, Groark S, Branch RA.

Clin Transl Sci. 2009 Oct;2(5):340-9. doi: 10.1111/j.1752-8062.2009.00155.x.

11.

Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.

Carr BI, Pancoska P, Branch RA.

Hepatol Int. 2009 Dec 24;4(1):396-405. doi: 10.1007/s12072-009-9157-7.

12.

HCC in older patients.

Carr BI, Pancoska P, Branch RA.

Dig Dis Sci. 2010 Dec;55(12):3584-90. doi: 10.1007/s10620-010-1177-6. Epub 2010 Mar 18.

PMID:
20238246
13.
14.

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.

Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, Kondragunta V, Lee JS, Zhang Y, Choi AM, Lokshin AE, Kaminski N, Gur D, Sciurba FC.

PLoS One. 2009 Aug 31;4(8):e6865. doi: 10.1371/journal.pone.0006865.

15.

Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study.

Carr BI, Buch SC, Kondragunta V, Pancoska P, Branch RA.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1259-66. doi: 10.1111/j.1440-1746.2008.05487.x.

PMID:
18699979
16.

Combination of hepatitis B viral factors and advanced liver disease in HBeAg-negative patients: the more, the worse?

Lin CL, Branch RA, Kao JH.

Gastroenterology. 2008 Apr;134(4):1270-1; author reply 1271. doi: 10.1053/j.gastro.2007.12.045. No abstract available.

PMID:
18395114
17.

Gender-based outcomes differences in unresectable hepatocellular carcinoma.

Buch SC, Kondragunta V, Branch RA, Carr BI.

Hepatol Int. 2008 Mar;2(1):95-101. doi: 10.1007/s12072-007-9041-2. Epub 2007 Dec 15.

18.

Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients.

Muindi JR, Roth MD, Wise RA, Connett JE, O'Connor GT, Ramsdell JW, Schluger NW, Romkes M, Branch RA, Sciurba FC; FORTE Study Investigators.

J Clin Pharmacol. 2008 Jan;48(1):96-107.

PMID:
18094222
19.

Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.

Lee JS, Rosengart MR, Kondragunta V, Zhang Y, McMurray J, Branch RA, Choi AM, Sciurba FC.

Respir Res. 2007 Sep 14;8:64.

20.

Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.

Juang P, Skledar SJ, Zgheib NK, Paterson DL, Vergis EN, Shannon WD, Ansani NT, Branch RA.

Am J Infect Control. 2007 Mar;35(2):131-7.

PMID:
17327194
21.

Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

Zgheib NK, Frye RF, Tracy TS, Romkes M, Branch RA.

Br J Clin Pharmacol. 2007 Apr;63(4):477-87. Epub 2006 Oct 19.

22.

Validation of incorporating flurbiprofen into the Pittsburgh cocktail.

Zgheib NK, Frye RF, Tracy TS, Romkes M, Branch RA.

Clin Pharmacol Ther. 2006 Sep;80(3):257-63.

PMID:
16952492
23.

Liver disease selectively modulates cytochrome P450--mediated metabolism.

Frye RF, Zgheib NK, Matzke GR, Chaves-Gnecco D, Rabinovitz M, Shaikh OS, Branch RA.

Clin Pharmacol Ther. 2006 Sep;80(3):235-45.

PMID:
16952490
24.

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL.

Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. Epub 2006 May 6.

PMID:
16680461
25.

Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation.

Liu S, Frye RF, Branch RA, Venkataramanan R, Fung JJ, Burckart GJ.

J Clin Pharmacol. 2005 Jun;45(6):666-73.

PMID:
15901748
26.

Cytochrome P-450 activity is differentially altered in severely injured patients.

Harbrecht BG, Frye RF, Zenati MS, Branch RA, Peitzman AB.

Crit Care Med. 2005 Mar;33(3):541-6.

PMID:
15753745
27.

Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects.

Suri A, Reddy S, Gonzales C, Knadler MP, Branch RA, Skinner MH.

Int J Clin Pharmacol Ther. 2005 Feb;43(2):78-84.

PMID:
15726876
28.

Bioequivalence revisited: influence of age and sex on CYP enzymes.

Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, Chaves-Gnecco D, Branch RA.

Clin Pharmacol Ther. 2004 Dec;76(6):618-27.

PMID:
15592333
29.

Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.

Carcillo JA, Adedoyin A, Burckart GJ, Frye RF, Venkataramanan R, Knoll C, Thummel K, Roskos L, Wilson JW, Sereika S, Romkes M, Bebia Z, Branch RA.

Clin Pharmacol Ther. 2003 May;73(5):456-67.

PMID:
12732845
30.

Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.

Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmöller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA, Rothman N.

Am J Epidemiol. 2002 Jul 15;156(2):95-109. Review. Erratum in: Am J Epidemiol 2002 Sep 1;156(5):492.

PMID:
12117698
32.

Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.

Conley EL, Coley KC, Pollock BG, Dapos SV, Maxwell R, Branch RA.

Pharmacotherapy. 2001 Nov;21(11):1325-30.

PMID:
11714204
33.

Lack of tacrolimus-induced cardiomyopathy.

Coley KC, Verrico MM, McNamara DM, Park SC, Cressman MD, Branch RA.

Ann Pharmacother. 2001 Sep;35(9):985-9.

PMID:
11573873
34.

Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone.

Hutzler JM, Frye RF, Korzekwa KR, Branch RA, Huang SM, Tracy TS.

Eur J Pharm Sci. 2001 Aug;14(1):47-52.

PMID:
11457649
35.

In vivo modulation of CYP enzymes by quinidine and rifampin.

Branch RA, Adedoyin A, Frye RF, Wilson JW, Romkes M.

Clin Pharmacol Ther. 2000 Oct;68(4):401-11.

PMID:
11061580
36.

A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections.

Adedoyin A, Swenson CE, Bolcsak LE, Hellmann A, Radowska D, Horwith G, Janoff AS, Branch RA.

Antimicrob Agents Chemother. 2000 Oct;44(10):2900-2.

37.

Changing physician prescribing behavior: the community-acquired pneumonia intervention trial.

Coley KC, Skledar SJ, Fine MJ, Yealy DM, Gleason PP, Ryan ML, Kapoor W, Branch RA.

Am J Health Syst Pharm. 2000 Aug 15;57(16):1506-10.

PMID:
10965396
38.

Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.

Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmöller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):461-7.

39.

Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.

Coley KC, Carter CS, DaPos SV, Maxwell R, Wilson JW, Branch RA.

J Clin Psychiatry. 1999 Dec;60(12):850-6.

PMID:
10665632
40.
41.

Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth.

Dubey RK, Tyurina YY, Tyurin VA, Gillespie DG, Branch RA, Jackson EK, Kagan VE.

Circ Res. 1999 Feb 5;84(2):229-39.

42.

The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.

Carcillo JA, Korzekwa KR, Jones GS, Parise RA, Gillespie DG, Whalen MJ, Kochanek PM, Branch RA, Kost CK Jr.

Res Commun Mol Pathol Pharmacol. 1998 Oct;102(1):57-68.

PMID:
9920346
43.

Drugs in liver disease.

Branch RA.

Clin Pharmacol Ther. 1998 Oct;64(4):462-5. No abstract available.

PMID:
9797803
44.

Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.

Adedoyin A, Frye RF, Mauro K, Branch RA.

Br J Clin Pharmacol. 1998 Sep;46(3):215-9. Erratum in: Br J Clin Pharmacol 1998 Dec;46(6):616.

45.

Teaching clinical pharmacology and therapeutics: selective for fourth-year medical students.

Tofovic SP, Branch RA, Jackson EK, Cressman MD, Kost CK Jr.

J Clin Pharmacol. 1998 Aug;38(8):670-9.

PMID:
9725541
46.

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.

Adedoyin A, Arns PA, Richards WO, Wilkinson GR, Branch RA.

Clin Pharmacol Ther. 1998 Jul;64(1):8-17.

PMID:
9695714
47.

Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.

Frye RF, Adedoyin A, Mauro K, Matzke GR, Branch RA.

J Clin Pharmacol. 1998 Jan;38(1):82-9.

PMID:
9597564
48.

Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.

Burckart GJ, Frye RF, Kelly P, Branch RA, Jain A, Fung JJ, Starzl TE, Venkataramanan R.

Clin Pharmacol Ther. 1998 Mar;63(3):296-302.

49.

All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes.

Adedoyin A, Stiff DD, Smith DC, Romkes M, Bahnson RC, Day R, Hofacker J, Branch RA, Trump DL.

Cancer Chemother Pharmacol. 1998;41(2):133-9.

PMID:
9443626
50.

Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis.

Arns PA, Adedoyin A, DiBisceglie AM, Waggoner JG, Hoofnagle JH, Wilkinson GR, Branch RA.

Clin Pharmacol Ther. 1997 Nov;62(5):527-37.

PMID:
9390109

Supplemental Content

Loading ...
Support Center